I. Pharmacologie-de-la-bivalirudine, .. , B. Pharmacocinétique, .. , C. Indications et al., 34 A. Mode d'action et pharmacodynamique, 35 E. Contre-indications, p.35

@. Abréviations, @. Cérébral, K. Vitamine, @. Glomérulaire, @. Electrocardiogramme et al., Bleeding Academic Research Consortium Débit de Filtration Glycoprotéine 2b Héparine de Bas Poids Moléculaire Percutaneous Coronary Intervention, Service Mobile d'Urgence et de Réanimation ? SCA ............... Syndrome Coronarien Aigu ? ST+ ............... Sus-décalage du segment ST sur l'électrocardiogramme Bibliographie [1] Longeaux N and Azema O. Rapport annuel 2011 sur l'activité des structures d'urgences en midi-pyrénées, 2011.

N. Danchin, E. Puymirat, and N. Aissaoui, ??pid??miologie des syndromes coronaires aigus en France et en Europe, Annales de Cardiologie et d'Ang??iologie, vol.59, issue.2, pp.37-41, 2010.
DOI : 10.1016/S0003-3928(10)70008-1

O. Gara, P. Kushner, F. Ascheim, and D. , AHA guideline for the management of ST-elevation myocardial infarction, ACCF J AM Health Association, vol.127, issue.4, pp.362-425, 2013.

E. Keeley, J. Boura, and C. Grines, Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials, The Lancet, vol.367, issue.9510, pp.367579-88, 2006.
DOI : 10.1016/S0140-6736(06)68148-8

P. Steg, A. Van-'t-hof, and C. Hamm, Bivalirudin Started during Emergency Transport for Primary PCI, New England Journal of Medicine, vol.369, issue.23, pp.2207-2224, 2013.
DOI : 10.1056/NEJMoa1311096

U. Zeymer, A. Van-'t-hof, and J. Adgey, Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial, European Heart Journal, vol.378, issue.9792, pp.352460-352467, 2014.
DOI : 10.1016/S0140-6736(11)60876-3

G. Stone, B. Witzenbichler, and G. Guagliumi, Bivalirudin during Primary PCI in Acute Myocardial Infarction, New England Journal of Medicine, vol.358, issue.21, pp.2218-2230, 2008.
DOI : 10.1056/NEJMoa0708191

G. Stone, B. Witzenbichler, and G. Guagliumi, Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial, The Lancet, vol.377, issue.9784, pp.3772193-204, 2011.
DOI : 10.1016/S0140-6736(11)60764-2

A. Go, D. Mozaarian, and V. Roger, Heart Disease and Stroke Statistics--2014 Update: A Report From the American Heart Association, Circulation, vol.129, issue.3, pp.28-292, 2014.
DOI : 10.1161/01.cir.0000441139.02102.80

M. Hanssen, Y. Cootin, and K. Khalife, French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010, Heart, vol.98, issue.9, pp.98699-705, 2012.
DOI : 10.1136/heartjnl-2012-301700

E. Puymirat, T. Simon, and P. Steg, Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction, JAMA, vol.308, issue.10, pp.998-1006, 2012.
DOI : 10.1001/2012.jama.11348

E. Puymirat, T. Simon, and P. Steg, Conférence de l'ESC 2012, FAST-MI. STEMI : la mortalité diminue grâce à une meilleure prise en charge globale

J. Tuomilehto, K. Kuulasmaa, and J. Torppa, MONitoring of trends and determinants in CArdiovascular disease

F. Schiele, Athérome : anatomie pathologique, épidémiologie, facteur de risque et prévention (page consultée le 11, 2015.

C. Kimmelstiel, P. Zhang, and N. Kapur, Bivalirudin Is a Dual Inhibitor of Thrombin and Collagen-Dependent Platelet Activation in Patients Undergoing Percutaneous Coronary Intervention, Circulation: Cardiovascular Interventions, vol.4, issue.2, pp.171-180, 2011.
DOI : 10.1161/CIRCINTERVENTIONS.110.959098

G. Stone, M. Bertrand, and A. Colombo, Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale, American Heart Journal, vol.148, issue.5, pp.764-75, 2004.
DOI : 10.1016/j.ahj.2004.04.036

H. Gurm, I. Sarembock, and D. Kereiakes, Use of Bivalirudin During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus, Journal of the American College of Cardiology, vol.45, issue.12, pp.451932-451940, 2005.
DOI : 10.1016/j.jacc.2005.02.074

G. Montalescot, U. Zeymer, and J. Silvain, Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial, The Lancet, vol.378, issue.9792, pp.378693-703, 2011.
DOI : 10.1016/S0140-6736(11)60876-3

G. Stone, B. Mclaurin, and D. Cox, Bivalirudin for Patients with Acute Coronary Syndromes, New England Journal of Medicine, vol.355, issue.21, pp.2203-2219, 2006.
DOI : 10.1056/NEJMoa062437

S. Schulz, G. Richardt, and K. Laugwitz, Comparison of Prasugrel and Bivalirudin vs Clopidogrel and Heparin in Patients With ST-Segment Elevation Myocardial Infarction: Design and Rationale of the Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 Trial, Clinical Cardiology, vol.116, issue.5, pp.270-276, 2014.
DOI : 10.1161/CIRCULATIONAHA.107.187397

A. Baumbach, T. Johnson, and V. Oriolo, Prasugrel and bivalirudin for primary angioplasty: Early results on stent thrombosis and bleeding, International Journal of Cardiology, vol.153, issue.2, pp.222-226, 2011.
DOI : 10.1016/j.ijcard.2011.09.059

D. Díaz, L. Llera, C. Gómez, J. Rangel, and D. , A comparative study of bivalirudin plus clopidogrel versus bivalirudin plus prasugrel in primary angioplasty using propensity score matching, J Interv Cardiol, vol.26, issue.5, pp.463-472, 2013.

S. Wiviott, E. Braunwald, and C. Mccabe, Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes, New England Journal of Medicine, vol.357, issue.20, pp.2001-2016, 2007.
DOI : 10.1056/NEJMoa0706482

G. Montalescot, S. Wiviott, and E. Braunwald, Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial, The Lancet, vol.373, issue.9665, pp.373723-373754, 2009.
DOI : 10.1016/S0140-6736(09)60441-4

M. Sejersten, S. Nielsen, and T. Engstrøm, Feasibility and Safety of Prehospital Administration of Bivalirudin in Patients With ST-Elevation Myocardial Infarction, The American Journal of Cardiology, vol.103, issue.12, pp.1635-1675, 2009.
DOI : 10.1016/j.amjcard.2009.02.015

J. Rassen, M. Mittleman, and R. Glynn, Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention, European Heart Journal, vol.115, issue.9, pp.561-72, 2010.
DOI : 10.1016/j.amjmed.2003.08.025

L. Jacquemin, O. Roth, and J. Wiedemann, Traitement pr??hospitalier par bivalirudine de l???infarctus aigu du myocarde orient?? vers une angioplastie primaire. ?? propos d???une s??rie cons??cutive de 152??cas, Annales de Cardiologie et d'Ang??iologie, vol.62, issue.4, pp.227-259, 2013.
DOI : 10.1016/j.ancard.2013.03.005

S. Carillo, Bivalirudine en préhospitalier dans l'angioplastie primaire : expérience du chu de nancy et comparaison avec une population traitée par abciximab, 2013.

J. Chandrasekhar and R. Mehran, The ideal anticoagulation strategy in ST-elevation myocardial infarction Publié en ligne, Prog Cardiovasc Dis, vol.15, pp.33-062000066

A. Shahzad, I. Kemp, and C. Mars, Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial, The Lancet, vol.384, issue.9957, pp.3841849-58, 2014.
DOI : 10.1016/S0140-6736(14)60924-7

R. Shelton, C. Eftychiou, and K. Somers, Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population, EuroIntervention, vol.9, issue.1, pp.118-142, 2013.
DOI : 10.4244/EIJV9I1A17

Y. Han, J. Guo, and Y. Zheng, Bivalirudin versus heparin and heparin plus tirofiban in patients with AMI undergoing PCI, JAMA, issue.13, pp.3131336-3131382, 2015.

M. Hamon, C. Nienaber, and S. Galli, Bivalirudin in percutaneous coronary intervention: The EUROpean BiValIrudin UtiliSatION in Practice (EUROVISION) Registry, International Journal of Cardiology, vol.173, issue.2, pp.290-294, 2014.
DOI : 10.1016/j.ijcard.2014.03.003

D. Pinto, P. Kohli, and W. Fan, Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database, Catheterization and Cardiovascular Interventions, vol.384, issue.3, 2015.
DOI : 10.1016/S0140-6736(14)60924-7

M. Valgimigli, E. Frigoli, and S. Leonardi, Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes, New England Journal of Medicine, vol.373, issue.11, pp.997-1009, 2015.
DOI : 10.1056/NEJMoa1507854

URL : https://boris.unibe.ch/71500/1/Valgimigli%20NEnglJMed%202015.pdf